Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Antiretroviral-Sparing Concept With HIV-specific T Cell Precursors With High Proliferative Capacity (PHPC)
Completed
- Conditions
- HIV Infection
- Interventions
- Biological: DermaVirBiological: PlaceboDrug: HAART
- First Posted Date
- 2009-06-11
- Last Posted Date
- 2013-02-08
- Lead Sponsor
- Genetic Immunity
- Target Recruit Count
- 16
- Registration Number
- NCT00918840
- Locations
- 🇮🇹
IRCCS Policlinico S. Matteo, Pavia, Italy
Single DermaVir Immunization in HIV-1 Infected Patients on HAART
Phase 1
Completed
- Conditions
- HIV Infection
- Interventions
- Biological: DermaVirDrug: HAART
- First Posted Date
- 2008-07-10
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Genetic Immunity
- Target Recruit Count
- 9
- Registration Number
- NCT00712530
- Locations
- ðŸ‡ðŸ‡º
Saint Laszlo Hospital, Budapest, Hungary
Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients
Phase 2
Completed
- Conditions
- HIV Infection
- First Posted Date
- 2008-07-08
- Last Posted Date
- 2020-01-28
- Lead Sponsor
- Genetic Immunity
- Target Recruit Count
- 36
- Registration Number
- NCT00711230
- Locations
- 🇩🇪
ifi-Medizin GmbH at the Asklepios Klinik St. Georg, Hamburg, Germany
🇩🇪ICH Grindel, Hamburg, Germany
🇩🇪University Medical Center Hamburg-Eppendorf, Hamburg, Germany
News
No news found